These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 16960866)
1. NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line. Morotti A; Cilloni D; Pautasso M; Messa F; Arruga F; Defilippi I; Carturan S; Catalano R; Rosso V; Chiarenza A; Taulli R; Bracco E; Rege-Cambrin G; Gottardi E; Saglio G Am J Hematol; 2006 Dec; 81(12):938-45. PubMed ID: 16960866 [TBL] [Abstract][Full Text] [Related]
2. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463 [TBL] [Abstract][Full Text] [Related]
3. [Mechanism related to inhibition of leukemia K562 cells by berbamine]. WEI YL; XU L; ZHAO XY Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):387-91. PubMed ID: 19693977 [TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. Heon Seo K; Ko HM; Kim HA; Choi JH; Jun Park S; Kim KJ; Lee HK; Im SY Cancer Res; 2006 May; 66(9):4681-6. PubMed ID: 16651419 [TBL] [Abstract][Full Text] [Related]
5. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. Rahmani M; Nguyen TK; Dent P; Grant S Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328 [TBL] [Abstract][Full Text] [Related]
6. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells. Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400 [TBL] [Abstract][Full Text] [Related]
7. Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma. Gabellini C; Castellini L; Trisciuoglio D; Kracht M; Zupi G; Del Bufalo D J Neurochem; 2008 Nov; 107(3):871-82. PubMed ID: 18786178 [TBL] [Abstract][Full Text] [Related]
8. Imatinib resistance in multidrug-resistant K562 human leukemic cells. Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528 [TBL] [Abstract][Full Text] [Related]
9. The actinomycin D-induced apoptosis in BCR-ABL-positive K562 cells is associated with cytoplasmic translocation and cleavage of RNA helicase A. Abdelhaleem M Anticancer Res; 2003; 23(1A):485-90. PubMed ID: 12680254 [TBL] [Abstract][Full Text] [Related]
10. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression. Batlle A; Papadopoulou V; Gomes AR; Willimott S; Melo JV; Naresh K; Lam EW; Wagner SD Mol Immunol; 2009 May; 46(8-9):1727-35. PubMed ID: 19268365 [TBL] [Abstract][Full Text] [Related]
11. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643 [TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway. Kurosu T; Ohki M; Wu N; Kagechika H; Miura O Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808 [TBL] [Abstract][Full Text] [Related]
13. Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53. Zhou M; Gu L; Zhu N; Woods WG; Findley HW Oncogene; 2003 Nov; 22(50):8137-44. PubMed ID: 14603254 [TBL] [Abstract][Full Text] [Related]
14. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Mendoza FJ; Ishdorj G; Hu X; Gibson SB Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578 [TBL] [Abstract][Full Text] [Related]
17. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells. Fukumi S; Horiguchi-Yamada J; Nakada S; Nagai M; Ohno T; Yamada H Mol Cell Biochem; 2000 Mar; 206(1-2):43-50. PubMed ID: 10839193 [TBL] [Abstract][Full Text] [Related]
18. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087 [TBL] [Abstract][Full Text] [Related]
19. Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-KappaB: Potentiation of cell death mediated by chemotherapeutic agents. Bose JS; Gangan V; Jain SK; Manna SK J Cell Physiol; 2009 Mar; 218(3):653-62. PubMed ID: 19034929 [TBL] [Abstract][Full Text] [Related]
20. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]